BioMarin Pharmaceutical | Activos Circulantes



Current Assets Cambio Fecha
Acadia Pharmaceuticals USD 960.55M 89.61M 2025-06
Agios Pharmaceuticals USD 1.02B 50.85M 2025-06
Alnylam Pharmaceuticals USD 3.64B 375.44M 2025-06
Amgen USD 26.73B 195M 2025-06
Bayer EUR 33.75B 1.08B 2025-06
Biogen USD 7.97B 341.7M 2025-06
BioMarin Pharmaceutical USD 3.81B 337.43M 2025-06
Gilead Sciences USD 14.72B 2.18B 2025-06
Incyte USD 3.64B 411.91M 2025-06
Insmed USD 2.08B 678.89M 2025-06
Ionis Pharmaceuticals USD 2.58B 158.22M 2025-06
Moderna USD 6.17B 595M 2025-06
Neurocrine Biosciences USD 1.75B 111M 2025-06
PTC Therapeutics USD 2.27B 43.53M 2025-06
Regeneron Pharmaceuticals USD 16.86B 712.2M 2025-06
Roche Holding CHF 40.04B 6.41B 2024-12
Sanofi 37.02B 5.57B 2025-06
Sarepta Therapeutics USD 2.66B 224.45M 2025-06
Ultragenyx Pharmaceutical USD 719.79M 20.63M 2025-06
United Therapeutics USD 3.83B 112.9M 2025-06
Vertex Pharmaceuticals USD 10.43B 419.1M 2025-06


BioMarin Pharmaceutical Activos Circulantes - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Sep 2025.